IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$284M
AUM Growth
+$26.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$12.6M
2
+$5.68M
3
+$4.84M
4
STML
Stemline Therapeutics, Inc.
STML
+$4.84M
5
EXEL icon
Exelixis
EXEL
+$4.74M

Top Sells

1
+$5.75M
2
+$5.23M
3
+$2.95M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$2.54M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2.36M

Sector Composition

1 Healthcare 91.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$1.14M 0.4%
20,000
52
$1.01M 0.36%
69,000
53
$956K 0.34%
+18,250
54
$928K 0.33%
+9,500
55
$883K 0.31%
14,779
56
$843K 0.3%
58,600
57
$834K 0.29%
20,953
58
$773K 0.27%
39,000
59
$660K 0.23%
34,000
-27,000
60
$617K 0.22%
12,000
61
$597K 0.21%
18,799
62
$562K 0.2%
+15,000
63
$395K 0.14%
18,000
64
$284K 0.1%
+70,000
65
– –
-425
66
– –
-83,000
67
– –
-70,446
68
– –
-170,000
69
– –
-9,400
70
– –
-153,633
1 2
3